pentobarbital will decrease the level or outcome of fedratinib by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Avoid or Use Alternate Drug. Outcome of coadministering a powerful CYP3A4 inducer with fedratinib has not been studied.
pentobarbital will reduce the extent or result of methadone by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Check.
네덜란드의 경우, 의사조력 자살의 표준 프로토콜은 정맥주사로 티오펜탈 마취를 한후, 브롬화물이나 알크로늄, 혹은 판큐로늄브롬화물을 주입하여 호흡기를 정지시킨다.
pentobarbital will minimize the level or effect of diclofenac by influencing hepatic enzyme CYP2C9/10 metabolism. Insignificant/Importance Unidentified.
pentobarbital will lower the extent or impact of buprenorphine subdermal implant by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Monitor Carefully. Observe individuals by now on buprenorphine subdermal implant who need recently-initiated procedure with CYP3A4 inducer for indicators and signs and symptoms of withdrawal.
pentobarbital will lessen the extent or influence of naloxegol by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Usage of naloxegol with strong CYP3A4 inducers is not really suggested
pentobarbital will minimize the level or influence of midazolam by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Watch.
pentobarbital will decrease the level or effect of iloperidone by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Monitor.
pentobarbital will lessen the level or outcome of sulfamethoxazole by impacting hepatic enzyme CYP2C9/10 metabolism. Minimal/Significance Not known.
pentobarbital will lessen the extent or outcome of ramelteon by impacting hepatic enzyme CYP2C9/10 metabolism. Small/Importance Unfamiliar.
pentobarbital will minimize the extent or result of quinine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Importance Unfamiliar.
pentobarbital will minimize the extent or influence of avanafil by impacting hepatic/intestinal enzyme CYP3A4 more info metabolism. Use Caution/Keep track of. For individuals with ED, monitor reaction diligently as a consequence of probable for diminished efficiency.
Parenteral answers of barbiturates are highly alkaline; Serious care should be taken to stop perivascular extravasation or intra-arterial injection; extravascular injection could cause community tissue injury with subsequent necrosis; consequences of intra-arterial injection may well vary from transient agony to gangrene in the limb; any complaint of agony while in the limb warrants stopping the injection
pentobarbital will lower the level or effect of bazedoxifene/conjugated estrogens by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Watch.